Does magnesium help sleep?

A guide to magnesium glycinate and L-threonate sleep research, including adult trial findings and evidence gaps for athletes.

What does the evidence show?

Key takeaways

  • Some adult trials show benefits on selected sleep outcomes.
  • Results do not establish consistent benefits across sleep measures.
  • Evidence does not identify a best formulation for athletes.

Research findings are mixed. Some adult trials report benefits on particular sleep questionnaires or wearable-derived scores, while other outcomes show no difference from placebo. The 2025 bisglycinate trial found a small improvement in insomnia severity. L-threonate trials reported improvements in some Oura sleep scores or sleep-related daytime impairment; these findings do not establish a consistent benefit across sleep measures.

These studies used different populations, formulations, doses, and outcomes. They do not establish which formulation works best for athletes. HERO Lab’s original and current athlete trials address separate research questions.

Which magnesium sleep studies actually involve athletes?

The three published trials below recruited adults with sleep complaints, not an athlete-specific cohort. HERO Lab’s two registered trials specifically study UCLA varsity athletes. Verified final athlete results are not available.

Adult trials and athlete protocols highlighted on this page
Study and populationOutcomes measuredEvidence status
2024 L-threonate trial80 adults aged 35–55 with self-reported sleep problems.Sleep questionnaires and Oura estimates, including sleep-stage minutes and scores.Published adult trial. Selected Oura scores differed; deep-sleep and REM-sleep minutes did not show significant group-by-time differences. Original paper.
2026 L-threonate trial100 adults aged 18–45 with self-reported dissatisfied sleep.Sleep-related impairment, sleep-disturbance and restorative-sleep questionnaires; Oura Ring 3 sleep measures.Published adult trial. Sleep-related impairment improved more than placebo; wearable sleep outcomes showed no significant between-group differences. Original paper.
2025 bisglycinate trial155 adults aged 18–65 with self-reported poor sleep.Insomnia Severity Index (primary) and other questionnaires. No objective sleep assessment.Published adult trial. Small benefit on insomnia symptoms; it does not establish an athlete benefit. Original paper.
Original HERO L-threonate trialUCLA varsity athletes aged 18–35. Final analysis population remains under review.Registered primary outcomes: WHOOP deep-sleep duration and HRV, from baseline to Week 4.Analysis under review. Earlier numerical estimates remain provisional. Registered protocol and dated status.
Fall 2026 HERO formulation trialUCLA varsity athletes aged 18–35; glycinate, L-threonate or placebo.Registered primary outcome: WHOOP sleep efficiency, from baseline week to final treatment week.In progress per study-team records; results are not available. Registered protocol and current study status.

The trials do not establish a best magnesium formulation for athletes. The athlete protocols use wearable-derived outcomes; registration and device use do not establish efficacy.

Published evidence and original sources

Read the findings, limitations, and funding disclosures alongside each paper. Study doses below describe research protocols, not dosing recommendations.

The Role of Magnesium in Sleep Health: A Systematic Review

Arab A, Rafie N, Amani R, Shirani F.

The review included nine studies with 7,582 participants. Observational studies suggested a relationship between magnesium status and sleep, but randomized trials produced inconsistent findings. The authors called for larger, better-designed trials.

PubMed

Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial

Hausenblas HA, Lynch T, Hooper S, et al.

Eighty adults aged 35–55 with self-reported sleep problems were assigned to 1 g/day magnesium L-threonate or placebo for 21 days. Some Oura deep-sleep and REM-sleep scores, readiness measures, and daytime-function measures favored L-threonate. However, actual deep-sleep and REM-sleep minutes, total sleep time, and sleep efficiency did not show significant group-by-time differences. A higher wearable score should not be read as proof of more deep sleep.

Funding & disclosures: AIDP commissioned and funded the study. Three authors disclosed paid roles with AIDP; the full conflict disclosure was added in a 2025 published correction.

PubMedOpen full textDOI: 10.1016/j.sleepx.2024.100121

The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial

Lopresti AL, Smith SJ.

One hundred adults aged 18–45 were randomized to 2 g/day magnesium L-threonate or placebo for six weeks. The trial reported benefits on selected cognitive tasks and self-reported sleep-related impairment. It found no significant between-group differences in wearable sleep outcomes, and not all self-reported sleep measures improved. The findings should not be summarized as a general improvement in sleep quality.

Funding & disclosures: Threotech funded the study, supplied the study product, and participated in developing the study design. The authors also disclosed professional relationships with the nutraceutical industry.

PubMedOpen full textDOI: 10.3389/fnut.2025.1729164

Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial

Schuster J, Cycelskij I, Lopresti A, Hahn A.

The trial randomized 155 adults with self-reported poor sleep to magnesium bisglycinate (250 mg elemental magnesium daily) or placebo for four weeks. Insomnia Severity Index scores fell by 3.9 points with magnesium and 2.3 with placebo. The between-group effect was small (Cohen’s d = 0.2; p = 0.049). Outcomes were questionnaire-based; the trial did not establish an improvement in objectively measured sleep.

Funding & disclosures: The Institute of Food and One Health at Leibniz University Hannover funded the study. Adrian Lopresti disclosed nutraceutical research and honoraria relationships.

PubMedOpen full textDOI: 10.2147/NSS.S524348

What is HERO Lab studying in athletes?

Original L-threonate trial: analysis under review

HERO Lab’s original UCLA athlete trial registered deep sleep duration and HRV as primary outcomes. Earlier numerical analyses remain provisional while source records and the final analysis plan are reconciled. The registry checked October 12, 2026 still lists active, not recruiting; completion details and masking descriptions remain to be reconciled. Read the dated research status and historical AMSSM poster.

Current formulation comparison

A separate Fall 2026 study comparing magnesium glycinate, L-threonate, and placebo in UCLA varsity athletes is in progress. Results are not yet available. Contact the study team for current openings. Explore the new study and registered protocol.

Want to get involved?

UCLA varsity athletes can ask about eligibility for the Fall 2026 magnesium formulation study. The study team confirms participation; researchers and partners can contact us about collaboration.

Back to the evidence library